Salam Rehana A, MacPhail Ceilidh, Das Jai K, Bhutta Zulfiqar A
BMC Public Health. 2013;13 Suppl 3(Suppl 3):S22. doi: 10.1186/1471-2458-13-S3-S22. Epub 2013 Sep 17.
More than 3.5 million women and children under five die each year in poor countries due to underlying undernutrition. Many of these are associated with concomitant micronutrient deficiencies. In the last decade point of use or home fortification has emerged to tackle the widespread micronutrient deficiencies. We in this review have estimated the effect of Micronutrient Powders (MNPs) on the health outcomes of women and children.
We systematically reviewed literature published up to November 2012 to identify studies describing the effectiveness of MNPs. We used a standardized abstraction and grading format to estimate the effect of MNPs by applying the standard Child Health Epidemiology Reference Group (CHERG) rules.
We included 17 studies in this review. MNPs significantly reduced the prevalence of anemia by 34% (RR: 0.66, 95% CI: 0.57-0.77), iron deficiency anemia by 57% (RR: 0.43, 95% CI: 0.35-0.52) and retinol deficiency by 21% (RR: 0.79, 95% CI: 0.64, 0.98). It also significantly improved the hemoglobin levels (SMD: 0.98, 95% CI: 0.55-1.40). While there were no statistically significant impacts observed for serum ferritin and zinc deficiency. Our analysis shows no impact of MNPs on various anthropometric outcomes including stunting (RR: 0.92, 95% CI: 0.81, 1.04), wasting (RR: 1.13, 95% CI: 0.91, 1.40), underweight (RR:0.96, 95% CI: 0.83, 1.10), HAZ (SMD: 0.04, 95% CI: -0.13, 0.22), WAZ (SMD: 0.05, 95% CI: -0.12, 0.23) and WHZ (SMD: 0.04, 95% CI: -0.13, 0.21), although showing favorable trends. MNPs were found to be associated with significant increase in diarrhea (RR: 1.04, 95% CI: 1.01, 1.06) with non-significant impacts on fever and URI.
Our analysis of the effect of MNPs in children suggests benefit in improving anemia and hemoglobin however the lack of impact on growth and evidence of increased diarrhea requires careful consideration before recommending the intervention for implementing at scale.
在贫困国家,每年有超过350万妇女和五岁以下儿童因潜在的营养不良而死亡。其中许多与同时存在的微量营养素缺乏有关。在过去十年中,使用点或家庭强化措施已出现,以解决普遍存在的微量营养素缺乏问题。在本综述中,我们评估了微量营养素粉(MNPs)对妇女和儿童健康结局的影响。
我们系统地回顾了截至2012年11月发表的文献,以确定描述MNPs有效性的研究。我们使用标准化的摘要和分级格式,通过应用标准的儿童健康流行病学参考组(CHERG)规则来评估MNPs的效果。
我们在本综述中纳入了17项研究。MNPs显著降低了34%的贫血患病率(RR:0.66,95%CI:0.57-0.77),57%的缺铁性贫血患病率(RR:0.43,95%CI:0.35-0.52)和21%的视黄醇缺乏患病率(RR:0.79,95%CI:0.64,0.98)。它还显著提高了血红蛋白水平(SMD:0.98,95%CI:0.55-1.40)。虽然未观察到血清铁蛋白和锌缺乏有统计学显著影响。我们的分析表明,MNPs对包括发育迟缓(RR:0.92,95%CI:0.81,1.04)、消瘦(RR:1.13,95%CI:0.91,1.40)、体重不足(RR:0.96,95%CI:0.83,1.10)、身高别体重(SMD:0.04,95%CI:-0.13,0.22)、体重别年龄(SMD:0.05,95%CI:-0.12,0.23)和身高别体重Z评分(SMD:0.04,95%CI:-0.13,0.21)在内的各种人体测量结局没有影响,尽管显示出有利趋势。发现MNPs与腹泻显著增加相关(RR:1.04,95%CI:1.01-1.06),对发热和上呼吸道感染没有显著影响。
我们对MNPs在儿童中的效果分析表明,在改善贫血和血红蛋白方面有益,然而在大规模推荐实施该干预措施之前,其对生长缺乏影响以及腹泻增加的证据需要仔细考虑。